
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Drug discovery enterprise that is integrating insights from cancer genomics with innovative capabilities in synthetic chemistry and tumor biology to generate novel small-molecule drugs to treat cancer.
Headlines from Mass High Tech about H3 BIOMEDICINE INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2011 |
| Ownership Type | Private |
| Markus Warmuth | President/CEO | |||
| Yutaka Ishizaka | SVP Planning/Operations | |||
| Lisa Marcaurelle | VP Discovery Chemistry | |||
| John Wang | VP Medicinal Chemistry | |||
| Takeshi Hamano | Director Planning/Operations |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Website | http://www.h3biomedicine.com |
| Revenue | Subscriber access only |
| Address |
300 Technology Sq 5th Floor Cambridge, MA, 02139 |
| Phone | 617-252-5000 |
| Website | www.h3biomedicine.com |